๐Ÿ“ข New Earnings In! ๐Ÿ”

Pacira BioSciences, Inc.

PCRX

Healthcare
Drug Manufacturers - Specialty & Generic
US

Company Overview

Detailed information about Pacira BioSciences, Inc.

Basic Information
Ticker: PCRX
Country: US
Headquarter: Tampa, FL
Employees: 788
Financial Information
Market Cap: $1.1 Billion
Currency: USD
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Stock Data provided by Financial Modeling Prep

Company Description

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Last Updated: Jul 2025

Here's what you can ask